A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 268,783 shares of JAZZ stock, worth $34 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
268,783
Previous 182,015 47.67%
Holding current value
$34 Million
Previous $19.4 Million 54.22%
% of portfolio
0.08%
Previous 0.05%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.57 - $116.37 $8.73 Million - $10.1 Million
86,768 Added 47.67%
268,783 $30 Million
Q2 2024

Aug 14, 2024

BUY
$103.94 - $118.98 $18.9 Million - $21.7 Million
182,015 New
182,015 $19.4 Million
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $7.88 Million - $9.39 Million
64,624 New
64,624 $8.36 Million
Q1 2023

May 15, 2023

BUY
$133.98 - $160.47 $10.2 Million - $12.2 Million
76,109 Added 644.99%
87,909 $12.9 Million
Q4 2022

Feb 14, 2023

SELL
$129.72 - $159.85 $49.3 Million - $60.8 Million
-380,100 Reduced 96.99%
11,800 $1.88 Million
Q3 2022

Nov 14, 2022

BUY
$126.59 - $161.18 $12.5 Million - $15.9 Million
98,631 Added 33.63%
391,900 $52.2 Million
Q2 2022

Aug 15, 2022

SELL
$141.59 - $168.66 $25.9 Million - $30.8 Million
-182,905 Reduced 38.41%
293,269 $45.8 Million
Q1 2022

May 16, 2022

SELL
$129.64 - $160.7 $63.2 Million - $78.4 Million
-487,650 Reduced 50.6%
476,174 $74.1 Million
Q4 2021

Feb 14, 2022

BUY
$119.87 - $145.67 $25.7 Million - $31.2 Million
214,524 Added 28.63%
963,824 $123 Million
Q3 2021

Nov 15, 2021

BUY
$128.64 - $184.79 $96.4 Million - $138 Million
749,300 New
749,300 $97.6 Million
Q4 2020

Feb 16, 2021

SELL
$140.71 - $165.05 $45.9 Million - $53.9 Million
-326,289 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$105.46 - $144.13 $2.09 Million - $2.86 Million
-19,850 Reduced 5.73%
326,289 $46.5 Million
Q2 2020

Aug 14, 2020

BUY
$95.68 - $121.88 $30.9 Million - $39.4 Million
323,439 Added 1424.84%
346,139 $38.2 Million
Q1 2020

May 15, 2020

BUY
$87.74 - $152.74 $1.99 Million - $3.47 Million
22,700 New
22,700 $2.26 Million
Q4 2019

Feb 14, 2020

SELL
$117.65 - $153.73 $25.5 Million - $33.4 Million
-216,943 Closed
0 $0
Q3 2019

Nov 15, 2019

BUY
$125.18 - $143.24 $27.2 Million - $31.1 Million
216,943 New
216,943 $27.8 Million
Q3 2018

Nov 14, 2018

SELL
$161.01 - $180.57 $5.64 Million - $6.32 Million
-35,000 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$146.33 - $183.18 $2.19 Million - $2.75 Million
-15,000 Reduced 30.0%
35,000 $6.03 Million
Q1 2018

May 15, 2018

BUY
$135.59 - $157.16 $6.78 Million - $7.86 Million
50,000 New
50,000 $7.55 Million
Q4 2017

Feb 14, 2018

SELL
$131.06 - $150.39 $9.79 Million - $11.2 Million
-74,700 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$142.62 - $155.6 $10.7 Million - $11.6 Million
74,700
74,700 $10.9 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.94B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.